StockData
Oncotelic Therapeutics, Inc. logo

Oncotelic Therapeutics, Inc. (OTLC) stock

OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.02+0.00 (+11.45%)

Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –

Oncotelic Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Oncotelic Therapeutics's operating margin for the twelve months ending Dec 31, 2023 was -9497.2%. For fiscal 2023 it was -9497.2%, against -435.7% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023-9497.2%−9061.5
FY2020Dec 31, 2020-435.7%+8280.1
FY2013Dec 31, 2013-8715.8%−3541.4
FY2012Dec 31, 2012-5174.4%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-337.4%–
Q3 FY2023Sep 30, 202320.7%–
Q2 FY2020Jun 30, 20201.0%–
Q1 FY2020Mar 31, 2020-777.1%–

More Oncotelic Therapeutics figures

See a number that looks wrong?